Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement

Table 3 Summary of indirect statistical comparisons between dalteparin and enoxaparin using the method of Bucher et al., (1997)

Comparison	RR: E vs. D	(95%CI)	P-Value
THR Patients: Placebo Trials
VTE	1.26	(0.85 - 1.88)	0.78
Major Bleeds	2.57	(0.22 - 29.8)	0.58
Thrombocytopenia	2.34	(0.22 - 24.4)	0.69
Death	0.80	(0.06 - 1.0)	0.90
THR Patients: UH Trials
VTE	1.30	(0.42 - 4.1)	0.49
Major Bleeds	NA
Thrombocytopenia	0.57	(0.03 - 11.4)	0.94
Death	NA	(0.03 - 17.9)	0.94

Abbreviations: RR = relative risk, D = dalteparin, E = enoxaparin, P = placebo, UH = unfractionated heparin, THR = total hip replacement, VTE = venous thromboembolic events, NA = data not available for calculation

ISSN: 1477-9560